With a market cap of $17.4 billion, Leidos Holdings, Inc. (LDOS) provides services and solutions for government and ...

"We are excited to collaborate with Scienture to enhance its commercial effectiveness,” said Paul Mignon, President, Deployment Solutions, Syneos Health. "Our team is committed to delivering tailored ...

The genetic testing company says the filing won’t change the way it stores or protects data, but experts are still urging ...

Tevogen Bio is driven by a team of highly experienced industry leaders and distinguished scientists with drug development and ...

U.S. stocks added to their year-to-date gains, finishing 2024 year with double-digit positive returns. Fund's fixed-income ...

Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” fourth quarter ...

HHS PULLS THE PLUG — The Trump administration is closing HHS’ long Covid office, according to an internal email seen by ...

Daniel Lubetzky invests in health and longevity companies through Camino Partners.

Hims & Hers Health (HIMS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Despite ongoing workforce and financial pressures across the healthcare industry, several large health systems managed to ...

Health care companies slid as traders retreated from high-risk issues. Shares of obesity-drug maker Novo Nordisk and Hims & Hers Health, the compounding pharmacy seeking to compete with the ...